🌎All you need is ❀️.

Joined December 2020
πŸ‘‰They say the Grand Canyon is one of the 7 wonders of the world. But standing here, I’m looking at the person who built my entire world. 🚁🌡 Crossing "Grand Canyon" off my mom’s bucket list is a small way to say THANK YOU for the massive lessons she’s instilled in me. She taught me: βœ…Discipline to keep going. βœ…Resilience to bounce back. βœ…Humility to stay grounded. βœ…Empathy to see and feel others. But above all, she taught me that true success isn't defined by a title or a destinationβ€”it’s defined by how you treat everyone with kindness and humanity. ❀️ The values that create truly impactful people are almost always first taught by a mother. Happy Mother’s Day to all of the mothers making the world a better place, one lesson at a time. 🌷 #MothersDay #BucketList #GrandCanyon #Leadership #Mentorship #Values #ProfessionalDevelopment #Gratitude #Inspiration #Humanity
2
10
641
Trial Tuesday! Dr. Matt Galsky of @IcahnMountSinai leads @ALLIANCE_org A032103/MODERN trial investigating if DNA released from tumor cells into the blood helps identify the best #immunotherapy treatment after surgery for #bladdercancer. More info: bit.ly/Alliance-A032103
4
5
809
What an honor to be speaking to the residents at Hospital Universitario @ Monterrey, Mexico. I have been welcome with such a great embrace πŸ‡²πŸ‡½ I love what I do @SylvesterCancer
1
1
32
1,281
Think Tank on rare cancers. Really a wonderful group of people dedicated to helping patients and create new therapeutic paradigms ⁦@VivekSubbiah⁩ ⁦@targetcancer⁩
1
7
4
47
11,992
We made it. In London boarding to Boston @nlinmd #ESMO25
7
5
59
7,224
πŸ‘ Such an inspiring evening celebrating Dr. Stephen Freedland, Dr. Neal Shore, and the EMBARK study investigators ! Click here NEJM just released πŸ‘‰ nejm.org/doi/full/10.1056/NE… Over dinner, we reflected on more than a decade of dedication by the EMBARK study team that led to this truly practice-changing results for our prostate cancer patients β€” fixed-duration therapy and Overall Survival #ESMO25 Honored to celebrate this milestone with great friends and colleagues @SFreedlandMD @ZakhariaYousef @aaparicioMD @urotoday @UrologyTimes @OncLive @PCFnews
3
6
20
1,794
Honored to share my πŸš€ SECOND simultaneous publication at #ESMO25 πŸš€, published in πŸ“– @AnnalsOfOncology πŸŽ‰ Our global leptomeningeal disease (#LMD) from #NSCLC cohort study (2,052 patients) sets benchmark outcomes for this rare population and generates hypotheses for interventional studies. Grateful πŸ™ ❀️ to my mentors, colleagues, friends, and mentees for their collaboration and inspiration throughout this journey 😜. We will continue to work and move together @KelseyPanMD @Alfdoc2 @HwakeleeMD @danieltanmd #LungCancer @myESMO @AnnalsOfOncology @MDAndersonNews
Thrilled to share our global, multicenter study on leptomeningeal disease in NSCLC. None of this is possible without the dedication of participating centers and shared commitment for the vulnerable pts! @ThomasW35874311 @LeXiuning @KelseyPanMD @danieltanmd @HwakeleeMD @Alfdoc2
1
21
2
89
12,473
Does chemotherapy affect the biology of BRAF V600E mCRC when combined with encorafenib + ceruximab? Answer appears to be YES! Very intriguing translational finding showing that addition of chemo to E+C reduces development of acquired RAS, MAP2K1 , and other mutations that drive resistance to BRAF + EGFR blockade. Will use this data in counseling patients why we add chemo to E+C in this pt population. πŸ‘ to BREAKWATER team for releasing translational data on their large 500 pt (‼️) analysis!! And congrats to the always amazing @skopetz for an incredible presentation- our @MDAndersonNews team remains so inspired by you!!
4
37
3
121
10,858
πŸ™ Thank you Dr. Brian Rini, Dr. Katy Beckermann , Dr. Petros Grivas, Dr. David Aggen, Dr. Neal Shore, and Dr. Neeraj Agarwal for joining me on @OncLive @UrologyTimes on Location. Click here πŸ‘‰ onclive.com/view/rounding-up… ❀️ talking about all of the practice changing data GU studies #ESMO25 πŸ‘ Phenomenal job by the 2025 scientific @myESMO co-chairs Dr. Myriam Chalabi and Dr. Toni Choueiri. Is this the greatest collection of practice changing GU studies ever in one meeting? @MyriamChalabi @DrChoueiri @brian_rini @katy_beckermann @Dr_Aggen @PGrivasMDPhD @nealshore @neerajaiims @urotoday @OncoAlert @oncodaily @brunolarvol
1
10
2
30
2,532
⭐️ESMO Presidential Dinner kicking off in Berlin πŸ‡©πŸ‡ͺ a constellation of oncology’s brightest stars & fiercest heroes. What an amazing location !!! The room is electric. #ESMO25 @myESMO @DrChoueiri @MyriamChalabi
2
10
68
5,215
⭐️What is the impact factor of this picture ? @OncoAlert @DrChoueiri Tim Yap @CCR_AACR EIC #AACR25 @AACR
6
1
92
3,977
‼️6–8h outpatient tarlatamab monitoring is feasible WITH patient education! ▫️6–8h outpt (n=30) v 48h inpt (n=58) monitoring w/ cycle 1 ▫️TRAEs: 93% v 100% ▫️Hospital/ER visit: 27% v 34% ▫️CRS any grade: 60% v 62%; serious: 17% v 22% ▫️ CRS resolved ~3 days for both @OncoAlert
Happy to share our recent @ESMO_Open paper on the #safety and #feasibility of #outpatient administration of #tarlatamab as part of the #DeLLphi300 study providing evidence that support less intensive monitoring at initiation of therapy. #LCSM 🫁 #SCLC @LuisPaz_Ares @NReguart @ShirishGadgeel and others πŸ˜€ sciencedirect.com/science/ar…
10
26
5,280
Enhancing Sexual Health for Cancer Survivors | American Society of Clinical Oncology Educational Book ascopubs.org/doi/full/10.120… #ASCO25
1
9
1
37
5,252